Lipocine Inc. Stock Analysis & AI Score
Lipocine Inc. (LPCN) has an ST Score of 52.4 (B-), driven by its Financial Strength (A+) and held back by its Valuation (D+). Analysts rate it Buy with a $5.00 price target (+139.2% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Lipocine Inc. (LPCN) has an ST Score of 52.4 (B-), driven by its Financial Strength (A+) and held back by its Valuation (D+). Analysts rate it Buy with a $5.00 price target (+139.2% upside).
- Strongest
- Financial StrengthA+
- Weakest
- ValuationD+
All factor grades
- Financial StrengthA+
- ForecastA
- GrowthB+
- ProfitabilityC
- MomentumC-
- ValuationD+
- Piotroski2/9
Contact
LPCN stock: frequently asked questions
What is LPCN's ST Score?
Lipocine Inc. (LPCN) has an ST Score of 52.4 (B-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is LPCN a buy, hold, or sell?
Analysts rate LPCN a Buy, with a price target of $5.00 (+139.2% vs the current price). Our ST Score grades it B- (52.4/100). The ST Score is a data-driven signal, not a recommendation.
What are LPCN's factor grades?
Valuation D+, Profitability C, Financial Strength A+, Momentum C-, Growth B+, Forecast A.
What is LPCN's valuation grade?
Lipocine Inc. (LPCN) earns a valuation grade of D+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is LPCN's growth grade?
Lipocine Inc. (LPCN) earns a growth grade of B+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is LPCN's profitability grade?
Lipocine Inc. (LPCN) earns a profitability grade of C, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is LPCN's financial strength grade?
Lipocine Inc. (LPCN) earns a financial strength grade of A+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for LPCN?
The average analyst price target for Lipocine Inc. (LPCN) is $5.00 from 9 analysts, which is +139.2% versus the recent price of $2.09.
What is LPCN's Piotroski score?
Lipocine Inc. (LPCN) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.